mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.5 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |